SinoMab BioScience Limited (HKG:3681)
1.760
-0.010 (-0.56%)
At close: Mar 27, 2026
SinoMab BioScience Employees
SinoMab BioScience had 61 employees as of June 30, 2025. The number of employees decreased by 34 or -35.79% since the number was reported on December 31, 2024.
Employees
61
Change
-34
Growth
-35.79%
Revenue / Employee
n/a
Profits / Employee
-1.92M HKD
Market Cap
2.44B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 61 | -34 | -35.79% | 61 | 0 |
| Dec 31, 2024 | 95 | -120 | -55.81% | 95 | 0 |
| Dec 31, 2023 | 215 | -67 | -23.76% | 215 | 0 |
| Dec 31, 2022 | 282 | -1 | -0.35% | 282 | 0 |
| Dec 31, 2021 | 283 | 105 | 58.99% | 283 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,629 |
| Frontage Holdings | 1,540 |
| AIM Vaccine | 1,493 |
| Jiangsu Recbio Technology | 507 |
| Mabpharm | 383 |
| Cutia Therapeutics | 298 |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 195 |
| Immunotech Biopharm | 173 |